Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs

S. Takamura(Social Insurance Saitama Chuo Hospital), Takuji Torimura(Omuta hospital), Tsubasa Tsutsumi(Kurume University), Machiko Kawaguchi(Kurume University), Yuichi Teraki(Social Insurance Saitama Chuo Hospital), Takekuni Nakama(Kurume University), Sumiko Nagoshi(Saitama Medical University), Eri Katayama(Kurume University), Takumi Kawaguchi(Kurume University), Dan Nakano(Kurume University)
Clinical and Molecular Hepatology
February 15, 2022
10.3350/cmh.2022.0040
Cited by 29

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
|Hepatology Research|2019|539
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
|Journal of Hepatology|2016|504